Prevalence of Different Gadolinium Enhancement Patterns in Patients After Heart Transplantation

Journal of the American College of Cardiology

Volumn 52, Issue 14, 2008, Pages 1160-1167

  Steen, Henning ^a   Merten, Constanze ^a   Refle, Sonja ^a   Klingenberg, Roland ^a   Dengler, Thomas ^a   Giannitsis, Evangelos ^a   Katus, Hugo A ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

atherosclerosis; coronary artery disease; heart transplantation; magnetic resonance imaging; myocardial infarction

Indexed keywords

GADOLINIUM PENTETATE;

ADULT; AGED; ANALYSIS OF VARIANCE; ANGIOCARDIOGRAPHY; ARTICLE; CARDIAC ALLOGRAFT VASCULOPATHY; CONTRAST ENHANCEMENT; FEMALE; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSSTOLIC VOLUME; HEART LEFT VENTRICLE VOLUME; HEART TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ADULT; AGED; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FEMALE; FIBROSIS; GADOLINIUM; HEART FUNCTION TESTS; HEART TRANSPLANTATION; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIUM;

EID: 51649101300     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.05.059     Document Type: Article

References (29)

1. Bennett L.E., Keck B.M., Daily O.P., Novick R.J., and Hosenpud J.D. Worldwide thoracic organ transplantation: a report from the UNOS/ISHLT International Registry for Thoracic Organ Transplantation. Clin Transpl (2000) 31-44
2. Robbins R.C., Barlow C.W., Oyer P.E., et al. Thirty years of cardiac transplantation at Stanford university. J Thorac Cardiovasc Surg 117 (1999) 939-951
3. Kocik M., Malek I., Janek B., Zelizko M., and Pirk J. Risk factors for the development of coronary artery disease of a grafted heart as detected very early after orthotopic heart transplantation. Transpl Int 20 (2007) 666-674
4. Li H., Tanaka K., Anzai H., et al. Influence of pre-existing donor atherosclerosis on the development of cardiac allograft vasculopathy and outcomes in heart transplant recipients. J Am Coll Cardiol 47 (2006) 2470-2476
5. Nicolas R.T., Kort H.W., Balzer D.T., et al. Surveillance for transplant coronary artery disease in infant, child and adolescent heart transplant recipients: an intravascular ultrasound study. J Heart Lung Transplant 25 (2006) 921-927
6. Weis M., and von Scheidt W. Coronary artery disease in the transplanted heart. Annu Rev Med 51 (2000) 81-100
7. Glagov S., Weisenberg E., Zarins C.K., Stankunavicius R., and Kolettis G.J. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 316 (1987) 1371-1375
8. Li H.Y., Tanaka K., Oeser B., Wertman B., Kobashigawa J.A., and Tobis J.M. Compensatory enlargement in transplant coronary artery disease: an intravascular ultrasound study. Chin Med J (Engl) 119 (2006) 564-569
9. Erley C.M., and Bader B.D. Consequences of intravascular contrast media on kidney function-risk and prevention. Rofo 172 (2000) 791-797
10. Billingham M.E., Cary N.R., Hammond M.E., et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. J Heart Transplant (1990) 587-593
11. Vriens P.W., Blankenberg F.G., Stoot J.H., et al. The use of technetium Tc 99m annexin V for in vivo imaging of apoptosis during cardiac allograft rejection. J Thorac Cardiovasc Surg 116 (1998) 844-853
12. Jackson E., Bellenger N., Seddon M., Harden S., and Peebles C. Ischaemic and non-ischaemic cardiomyopathies-cardiac MRI appearances with delayed enhancement. Clin Radiol 62 (2007) 395-403
13. Mahrholdt H., Wagner A., Judd R.M., Sechtem U., and Kim R.J. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J 26 (2005) 1461-1474
14. Billingham M.E., Cary N.R., Hammond M.E., et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: heart rejection study group. The International Society for Heart Transplantation. J Heart Transplant 9 (1990) 587-593
15. CMR Image Acquisition Protocols. http://www.scmr.org/documents/scmr_protocols_2007.pdf Accessed April 11, 2007
16. Steen H., Giannitsis E., Futterer S., Merten C., Juenger C., and Katus H.A. Cardiac troponin T at 96 hours after acute MI correlates with infarct size and cardiac function. J Am Coll Cardiol 48 (2006) 2192-2194
17. Cerqueira M.D., Weissman N.J., Dilsizian V., et al., American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 105 (2002) 539-542
18. Assomull R.G., Prasad S.K., Lyne J., et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 48 (2006) 1977-1985
19. Gao S.Z., Alderman E.L., Schroeder J.S., Silverman J.F., and Hunt S.A. Accelerated coronary vascular disease in the heart transplant patient: coronary arteriographic findings. J Am Coll Cardiol 12 (1988) 334-340
20. Billingham M.E. Graft coronary disease: the lesions and the patients. Transplant Proc 21 (1989) 3665-3666
21. Mark P.B., Johnston N., Groenning B.A., et al. Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging. Kidney Int 69 (2006) 1839-1845
22. Mahrholdt H., Wagner A., Deluigi C.C., et al. Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation 114 (2006) 1581-1590
23. Pereira N.L., Zile M.R., Harley R.A., and Van Bakel A.B. Myocardial mechanisms causing heart failure early after cardiac transplantation. Transplant Proc 38 (2006) 2999-3003
24. Maceira A.M., Joshi J., Prasad S.K., et al. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 111 (2005) 186-193
25. Moon J.C., Sheppard M., Reed E., Lee P., Elliott P.M., and Pennell D.J. The histological basis of late gadolinium enhancement cardiovascular magnetic resonance in a patient with Anderson-Fabry disease. J Cardiovasc Magn Reson 8 (2006) 479-482
26. Moon J.C., Mundy H.R., Lee P.J., Mohiaddin R.H., and Pennell D.J. Images in cardiovascular medicine. Myocardial fibrosis in glycogen storage disease type III. Circulation 107 (2003) e47
27. Marckmann P., Skov L., Rossen K., et al. Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am Soc Nephrol 17 (2006) 2359-2362
28. Rodby R.A. Dialytic therapies to prevent NSF following gadolinium exposure in high-risk patients. Semin Dial 21 (2008) 145-149
29. Thomsen H.S., and Morcos S.K. Contrast media and the kidney: European Society of Urogenital Radiology (ESUR) guidelines. Br J Radiol 76 (2003) 513-518